Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

China flag China · Delayed Price · Currency is CNY
16.94
+0.05 (0.30%)
Mar 18, 2026, 3:04 PM CST
Market Cap28.30B +19.1%
Revenue (ttm)6.01B -25.8%
Net Income-278.89M
EPS-0.17
Shares Out1.67B
PE Ration/a
Forward PE23.53
Dividend0.60 (3.55%)
Ex-Dividend DateOct 22, 2025
Volume8,202,604
Average Volume13,898,136
Open16.88
Previous Close16.89
Day's Range16.75 - 16.99
52-Week Range12.41 - 21.58
Beta0.65
RSI42.87
Earnings DateApr 28, 2026

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is base... [Read more]

Sector Healthcare
Founded 1992
Employees 11,708
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002603
Full Company Profile

Financial Performance

Financial Statements